Skip to main content
FinSpry Logo
FinSpry
NVO logo
NVO
(NYSE)
Novo Nordisk A/S
$46.60-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Novo Nordisk A/S (NVO) Stock Price & Financial Analysis

Novo Nordisk A/S Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$46.04 - $46.74
52-Week High$64.16
52-Week Low$35.12
Open$46.35
Volume6.10M
Average Volume (3M)12.86M
Market Cap207.31B
Shares Outstanding4.45B
P/E Ratio (TTM)10.93
Forward P/E9.37
Price to Sales (P/S)4.07
Price to Book (P/B)6.56
EV/EBITDA8.08
Revenue (TTM)50.99B
Net Income (TTM)18.97B
Free Cash Flow (TTM)4.96B
EPS (TTM)$4.27
Profit Margin37.20%
Operating Margin45.30%
Return on Equity (ROE)60.06%
Debt to Equity0.72
50-Day MA$47.89
200-Day MA$46.35
52-Week Change-15.63%
Annual Dividend$3.52
Dividend Yield7.56%
Payout Ratio82.60%
Last Dividend Ex-DateAug 25, 2027

Frequently Asked Questions About Novo Nordisk A/S

What is the current stock price for NVO?

As of the latest trading session, NVO stock trades at $46.60. The 52-week range is $35.12–$64.16, with a day range of $46.04–$46.74.

What is the P/E ratio for NVO?

Novo Nordisk A/S's trailing P/E ratio is 10.9, meaning investors pay $10.9 for every $1 of annual earnings. The forward P/E is 9.4, reflecting analyst expectations for future earnings. Novo Nordisk A/S operates in the Healthcare sector.

Does NVO pay dividends?

Yes, Novo Nordisk A/S pays a 7.56% annual dividend yield ($3.52 per share). The payout ratio is 82.6%. The last ex-dividend date was 2027-08-25.

What do analysts recommend for NVO?

Based on 3 analysts, the consensus for NVO is Hold.

What is the market cap of NVO?

Novo Nordisk A/S's market capitalization is $207.31B, classifying it as a mega-cap company. Novo Nordisk A/S operates in the Healthcare sector within the Drug Manufacturers - General industry.